| Barth syndrome: exploring cardiac metabolism with induced pluripotent stem cell-derived cardiomyocytes EM Fatica, GA DeLeonibus, A House, JV Kodger, RW Pearce, RR Shah, ... Metabolites 9 (12), 306, 2019 | 30 | 2019 |
| Metabolic outcomes of anaplerotic dodecanedioic acid supplementation in very long chain acyl-CoA dehydrogenase (VLCAD) deficient fibroblasts I Radzikh, E Fatica, J Kodger, R Shah, R Pearce, YI Sandlers Metabolites 11 (8), 538, 2021 | 6 | 2021 |
| A liquid chromatography tandem mass spectrometry method for a semiquantitative screening of cellular acyl-CoA RW Pearce, JV Kodger, YI Sandlers Analytical Biochemistry 640, 114430, 2022 | 4 | 2022 |
| No Cardiomyopathy or Skeletal Muscle Weakness in an Organismal Model of Barth Syndrome-Is Metabolism the Basis for Its Neutropenia? U Oyarbide Cuervas-Mons, J Kodger, S del Rio, Y Sandlers, SJ Corey Blood 140 (Supplement 1), 5472-5472, 2022 | 1 | 2022 |
| INVESTIGATION OF TAZ METABOLISM AND THERAPEUTIC AGENTS IN BARTH SYNDROME JV Kodger Cleveland State University, 2024 | | 2024 |
| B-170 Identifying Metabolic Phenotyping Variability in a Cellular Model of Barth Syndrome J Kodger Clinical Chemistry 69 (Supplement_1), hvad097. 502, 2023 | | 2023 |
